Answers are grounded in this paper and cite their sources.
The narcotic antagonist EN-1639A (naltrexone) was studied in 37 heroin addicts and found to be clinically useful, with a low incidence of side effects, lack of toxicity, high degree of acceptability to the patient, and capacity to antagonize the euphoric effects of heroin for up to 72 hours after a single oral dose. These findings provide a basis for expanding studies of the clinical efficacy of naltrexone in the treatment of opiate dependence.
No takes yet. Share an insight, caveat, or question.
Resnick et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: